NeuroSave Status
The company closed on $200,000 of convertible debt financing from Synergy Ventures and other undisclosed investors on August 10, 2017. Previously, the company raised $1.5 million of angel funding from undisclosed investors in 2013.
Developer of a medical therapy designed to prevent and treat ischemic brain injury. The company's medical therapy are used prevent and treat ischemic brain injury caused by surgery, cardiac arrest, stroke and trauma, enabling doctors to get device that helps in cooling down the brain during cardiac surgery.
Year Founded
2010
Employees
4
General Information
-
Website
-
Business Status
Generating Revenue
-
Ownership Status
Privately Held (backing)
-
Financing Status
Accelerator/Incubator Backed
NeuroSave News and Updates
Best Veterans Day sales
CNET | April 28, 2022
The Future of Therapeutic Hypothermia for Stroke
Medscape | May 22, 2020
NeuroARC Proposes New Standards for Assessing Neurologic ...
TCTMD | February 7, 2017
NeuroSave's Verticals
NeuroSave Primary Industry Sector / Group / Code
NeuroSave's Trends
Headquarters
-
HQ Address Line 1953 Indiana Street
-
HQ CitySan Francisco
-
HQ State/ProvinceCalifornia
-
HQ Post Code94107
-
HQ CountryUnited States
NeuroSave's Keywords
mood_badFeed is empty.
Add a review